We are live on ! Find out more
OGEN icon

Oragenics
OGEN

16 hedge funds and large institutions have $8.63M invested in Oragenics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

888% more capital inflows, than outflows

Capital inflows: $119K | Capital outflows: $12K

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

23% more funds holding

Funds holding: 13 → 16 (+3)

0.17% more ownership

Funds ownership: 39.68% → 39.85% (+0.17%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$53.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$21.5K
3
Parametric Portfolio Associates
Parametric Portfolio Associates
Washington
+$21.5K
4
Brandes Investment Partners
Brandes Investment Partners
California
+$10.8K
5
Northern Trust
Northern Trust
Illinois
+$10.8K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
2
Creative Planning
Creative Planning
Kansas
-$3K

OGEN Hedge Fund Activity: Q1 2017 in Review

16 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2017, worth a combined $8.63M — down 18% from $10.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OGEN positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Wells Fargo, opening a new position worth an estimated $53.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $9K sold.

  • 16 institutional investors held Oragenics (OGEN) as of Q1 2017, up from 13 in Q4 2016.
  • Funds reported $8.63M of Oragenics stock for Q1 2017, down 18% quarter-over-quarter.
  • 4 funds opened new Oragenics positions in Q1 2017 and 1 closed out, a net change of +3 holders.
  • The largest Oragenics buyer in Q1 2017 was Wells Fargo, an estimated $53.9K added.
  • The largest Oragenics seller in Q1 2017 was Susquehanna International Group, an estimated $9K sold.

Based on aggregated 13F filings for Q1 2017.